Antibody–drug conjugates (ADCs) consist of three components: a monoclonal antibody, a linker, and a cytotoxic payload. The antibody is responsible for recognizing tumor-associated antigens, the payload is responsible for killing cells, and the linker determines whether the payload can be safely ...
Antibo-drug conjugate (ADCs) combines the high specificity of antibodies with the strong cytotoxicity of small-molecule drugs. This combination combines the antibody's unique and very sensitive targeting ability to distinguish between healthy and cancerous tissue. It also has the cell-killing ...